Utama › Degenerasi Makula › Tennessee
Kajian klinikal Degenerasi Makula di Tennessee
7 kajian untuk Degenerasi Makula sedang mencari peserta di lokasi di Tennessee.
Bandar di Tennessee
Teks kajian rasmi (Bahasa Inggeris)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Charles Retina Institute, Germantown
Mengambil pesertaFasa 2/3
Umur 50 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07440225A Study in Adults With Geographic Atrophy
- Tennessee Retina, PC, Nashville
Mengambil pesertaFasa 2
Umur 60 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Tennessee Retina, PC, Nashville
- Vanderbilt Eye Institute, Nashville
Mengambil pesertaFasa 3
Umur 50 hingga 85 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Vanderbilt Eye Institute, Nashville
Mengambil pesertaFasa 2
Umur 55 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT066594454D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Tennessee Retina, Nashville
Mengambil pesertaFasa 1/2
Umur 50 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Southeastern Retina Associates, Hixson
- Southeastern Retina Associates (Site 095), Johnson City
- Southeastern Retina Associates, P.C., Knoxville
- dan 1 lagi
Mengambil pesertaFasa 2/3
Umur 50 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07496567Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Tennessee Retina, PC, Nashville
Mengambil pesertaFasa 3
Umur 50 ke atas · Semua jantina · Dikemas kini 16 Apr 2026 · NCT07064759Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.